Faculty Directory
Our Faculty has grown to over 100 exceptional researchers focused in a variety of research specialties
The ‘Laboratory for RNA-Based Lifeforms’ is focused on deciphering how genetic information encodes itself into RNA genes and viruses.
Structure-function relationship of human enteric adenovirus interactions with host cells. Antiviral host response. Antiviral effect of digoxin.
Our research examines the interactions of pathogenic bacteria with cells of their host.
My research focuses on manipulating cellular processes essential for replication of multiple viruses as an alternative approach to novel therapeutics.
Research in the Cowen lab focuses on the biology and evolution of fungal pathogens
Research in the Davidson Lab is aimed at phages, systems used by bacteria to resist phage attacks and how phages overcome these systems
Researchers in the Ensminger lab study an unusual class of bacterial effectors ("metaeffectors"), CRISPR-Cas, phage, and toxin-antitoxin systems.
My lab identifies and studies novel functions of Epstein-Barr virus proteins in manipulating cellular processes to promote cell survival and infection.
The Fraser Lab uses systematic approaches in C. elegans to probe basic problems in genetics
*Professor Emerita* interested in bacterial plasmid segregation/partition
The Gray-Owen research group aims to understand how human bacterial and viral pathogens colonize host tissues and evade the host immune response
RNA interactions and regulatory roles of human C2H2 zinc finger proteins; human proteins that become essential after viral infection as drug targets
Mechanism and function of non-coding small RNA in Mycobacterium tuberculosis; Immune mechanisms of protection against MTB and vaccine development.
We study new innate immune systems that we have discovered to prevent the pathogenic over proliferation of an RNA virus that infects budding yeast.
The gut microbiota, bacterial pathogens and microbial evolution.
We apply genomics and systems approaches to study how pathogens interact with microbial communities and their host to cause disease.
We study the ubiquitous eukaryotic parasite microsporidia using C. elegans and a variety of techniques including genetics, genomics, and biochemistry.
Structural and biochemical characterization of Coronavirus receptor interactions, antibody-mediated neutralization, and viral evolution.
New Technologies to Identify Novel Drug Candidates, Novel Infectious Disease Drug Targets, C. elegans Models of Disease, Xenobiotic Response Circuitry
We take an RNA-centric approach, relying on systems biology and virology, to better understand arbovirus infection in mammalian and mosquito models.